25 unchanged sentences
(the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024, based on the COSO criteria.
−Removed: We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2023 and 2022, the related consolidated statements of operations and comprehensive loss, stockholders’ equity (deficit) and cash flows for each of the two years in the period ended December 31, 2023, and the related notes and our report dated March 7, 2024 expressed an unqualified opinion thereon.
+Added: We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2024 and 2023, the related consolidated statements of operations and comprehensive loss, stockholders’ equity (deficit) and cash flows for each of the three years in the period ended December 31, 2024, and the related notes and our report dated March 4, 2025 expressed an unqualified opinion thereon.
Basis for Opinion
40 unchanged sentences
(2) Financial Statement Schedules.
−Removed: Financial statement schedules have been omitted because they are not applicable.
+Added: Financial statement schedules have been omitted because they are not applicable or the information called for is shown either in the consolidated financial statements or in the notes thereto.
(3) Exhibits.
13 unchanged sentences
4.3 Description of Securities
+Added: 001-38381 4.3
Stock Purchase Agreement, dated as of September 30, 2014, by and between Strathspey Crown Holdings, LLC and ALPHAEON Corporation.
+Added: 001-38381 10.1
Amendment to Stock Purchase Agreement, dated as of September 30, 2014, by and between Strathspey Crown Holdings, LLC and ALPHAEON Corporation.
+Added: 001-38381 10.2
10.3‡ License and Supply Agreement, dated as of September 30, 2013, by and between Daewoong Pharmaceutical Co., Ltd.
3 unchanged sentences
and the Registrant.
+Added: 001-38381 10.4
Second Amendment to License and Supply Agreement, dated as of July 15, 2014, by and between Daewoong Pharmaceutical Co., Ltd.
and the Registrant.
+Added: 001-38381 10.5
10.6+ 2017 Omnibus Incentive Plan.
22 unchanged sentences
Christopher Marmo, as Contributors’ Representative, and acknowledged by the parties listed as Contributors on the signature pages thereto.
−Removed: S-1 333-222478 10.20 1/9/18
Employment Agreement, dated as of May 6, 2018, by and between David Moatazedi and the Registrant.
45 unchanged sentences
10-Q 001-38381 10.2 11/7/23
−Removed: L icense , Sup ply , and Distribution Agreement (Europe), dated as of December 20, 2024, by and between Evolus Pharma B.V.
−Removed: and Sy matese Ae sthetics S.A.S
+Added: License, Supply, and Distribution Agreement (Europe), dated as of December 20, 2024, by and between Evolus Pharma B.V.
+Added: and Symatese Aesthetics S.A.S
+Added: 001-38381 10.35
First Amendment to Lease, dated as of July 27, 2023, by and between the Registrant and 520 Newport Center Drive LLC
+Added: 001-38381 10.36
+Added: Sixth Amendment to Supply Agreement, dated as of February 22, 2024, by and between Daewoong Pharmaceutical Co.
+Added: and Evolus, Inc.
+Added: 001-38381 10,1
+Added: S econd Amendment to Lease, dated as of October 16, 2024 , by and between t h e Registrant and 520 Newport Center Drive LLC
+Added: 2 024 Employee Stock Purchase Plan
+Added: 001-38381 10.1
+Added: Insider Trading Policy
21.1 List of Subsidiaries.
14 unchanged sentences
Indicates management contract or compensatory plan.
−Removed: The Registrant has omitted and filed separately with the Securities and Exchange Commission portions of the exhibit pursuant to a confidential treatment request under Rule 406 promulgated under the Securities Act of 1933, as amended, or the Securities Act.
‡ Portions of this exhibit have been omitted pursuant to Item 601(b)(10) of Regulation S-K.
21 unchanged sentences
/s/ Simone Blank Director March 4, 2025
−Removed: /s/ Robert Hayman Director March 7, 2024
−Removed: Robert Hayman
/s/ David Gill Director March 4, 2025
1 unchanged sentence
Karah Parschauer
−Removed: Signature Title Date
/s/ Brady Stewart Director March 4, 2025
Brady Stewart
+Added: Signature Title Date
+Added: /s/ Albert G.
+Added: Director March 4, 2025
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.